RESULTS OF A RANDOMIZED PHASE III TRIAL OF SEQUENTIAL INTRAVESICAL THERAPY WITH MITOMYCIN C AND BACILLUS CALMETTE-GUERIN VERSUS MITOMYCIN C ALONE IN PATIENTS WITH SUPERFICIAL BLADDER CANCER
Authors:
- 1 November 1998
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 160 (5) , 1668-1672
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A Combined Analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council Randomized Clinical Trials for the Prophylactic Treatment of Stage TaT1 Bladder CancerJournal of Urology, 1996
- Alternating Mitomycin C and Bacillus Calmette-Guerin Instillation Prophylaxis For Recurrent Papillary (Stages Ta to T1) Superficial Bladder CancerJournal of Urology, 1996
- Alternating Mitomycin C and Bacillus Calmette-Guerin Instillation Therapy for Carcinoma in Situ of the BladderJournal of Urology, 1995
- Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma: a multicenter phase II study.Journal of Clinical Oncology, 1991
- Combined interferon alf a and doxorubicin in the treatment of advanced cervical cancerAmerican Journal of Obstetrics and Gynecology, 1991
- Adverse Impact of Fibrin Clot Inhibitors on Intravesical Bacillus Calmette-Guerin Therapy for Superficial Bladder TumorsJournal of Urology, 1990
- Interferon Alpha-2a and Vinblastine in the Treatment of Metastatic Renal CarcinomaEuropean Urology, 1989
- Chemoimmunoprophylaxis of an Experimental Bladder Cancer with Retinoids and Bacillus Calmette GuérinJournal of Urology, 1983
- Analysis of the principles underlying chemo-immunotherapy of mouse tumoursCancer Immunology, Immunotherapy, 1979
- Effect of intralesional and systemic BCG-application or a combined cyclophosphamide/BCG treatment on experimental bladder cancerUrological Research, 1979